Vireo Yellow products are predominantly THC, with a small component of CBD. With all Vireo products, a baseline level of CBD is present, since some studies suggest that CBD can reduce unpleasant side effects of THC.Vireo Yellow Prefilled Vaporizer Cartridge ,Alien OG, Banana Pancakes, Banana Kush, Grape Ape,

The primary active ingredients in this medication are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

THC: 214 mg/cartridge
CBD: 36 mg/cartridge

Product Description

Vireo Yellow distillate products have a 1:6 ratio of CBD to THC.

The primary active ingredients in this medication are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

THC: 685.7 mg/cartridge
CBD: 114.3 mg/cartridge

Special Discounts are available for:

• Patients visiting us for the first time
• Patients who receive medical assistance including Supplemental Security Income (SSI), Social Security Disability (SSD), Medical Assistance, CHAMPVA, Veteran Affairs, Indian Health Service or Medicaid ID.
• Military patients of active or veteran status
• Spouse or children of military patients

Special discounts CANNOT be combined.

(Battery sold separately)

MINNEAPOLIS, July 25, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the “Company”) (CSE: VREO), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company filed a patent application with United States Patent and Trademark Office (“USPTO”) for a multichannel vaporizer designed to hold at least two vaporizer cartridges. The device will allow a user to adjust the mixture of vapor coming from each cartridge using a simple interface.

“Vireo Health is committed to helping consumers find their ‘cannabis sweet spot’ whether they are a connoisseur or a first-time user,” said Founder and CEO Kyle Kingsley, M.D.

About Vireo Health International, Inc.

Vireo’s physician-led team of more than 350 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently is licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico, and Rhode Island.  For more information about the company, please visit www.vireohealth.com.